Diet-induced metabolic disturbances as modulators of brain homeostasis - PubMed (original) (raw)
Review
Diet-induced metabolic disturbances as modulators of brain homeostasis
Le Zhang et al. Biochim Biophys Acta. 2009 May.
Abstract
A number of metabolic disturbances occur in response to the consumption of a high fat western diet. Such metabolic disturbances can include the progressive development of hyperglycemia, hyperinsulemia, obesity, metabolic syndrome, and diabetes. Cumulatively, diet-induced disturbances in metabolism are known to promote increased morbidity and negatively impact life expectancy through a variety of mechanisms. While the impact of metabolic disturbances on the hepatic, endocrine, and cardiovascular systems is well established there remains a noticeable void in understanding the basis by which the central nervous system (CNS) becomes altered in response to diet-induced metabolic dysfunction. In particular, it remains to be fully elucidated which established features of diet-induced pathogenesis (observed in non-CNS tissues) are recapitulated in the brain, and identification as to whether the observed changes in the brain are a direct or indirect effect of peripheral metabolic disturbances. This review will focus on each of these key issues and identify some critical experimental questions which remain to be elucidated experimentally, as well as provide an outline of our current understanding for how diet-induced alterations in metabolism may impact the brain during aging and age-related diseases of the nervous system.
Figures
Figure 1. Progression from euglycemic state to diabetes
In contrast to the a healthy euglycemic state, the consumption of a western diet is sufficient to increase the dysfunction of a number of aspects of metabolism. The temporal profile by which many on these metabolic disturbances occur is provided to allow for identification of early and late events in the progression to diabetes. HDL: high density lipoprotein; BMI: body mass index.
Figure 2. Diet-induced increases in brain dysfunction and brain pathology
Consumption of a western diet is sufficient to promote metabolic dysfunction that can then lead to the development of brain pathology and cognitive disturbances. Aging likely promotes the ability of a western diet to promote metabolic dysfunction, and deleterious effects on the brain, while several clinically relevant interventions (western diet cessation, antioxidants, anti-inflammatory, anti-diabetics) likely ameliorate the effects of a western diet on metabolism and the brain.
Similar articles
- Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.
Uranga RM, Bruce-Keller AJ, Morrison CD, Fernandez-Kim SO, Ebenezer PJ, Zhang L, Dasuri K, Keller JN. Uranga RM, et al. J Neurochem. 2010 Jul;114(2):344-61. doi: 10.1111/j.1471-4159.2010.06803.x. Epub 2010 May 6. J Neurochem. 2010. PMID: 20477933 Free PMC article. Review. - Lipid Nutrition and Healthy Aging.
Yanagita T, Miyazawa T. Yanagita T, et al. J Nutr Sci Vitaminol (Tokyo). 2015;61 Suppl:S157-8. doi: 10.3177/jnsv.61.S157. J Nutr Sci Vitaminol (Tokyo). 2015. PMID: 26598837 - Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K, Robotka H, Toldi J, Vécsei L. Sas K, et al. J Neurol Sci. 2007 Jun 15;257(1-2):221-39. doi: 10.1016/j.jns.2007.01.033. Epub 2007 Apr 25. J Neurol Sci. 2007. PMID: 17462670 Review. - Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases.
Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M, Zera T. Szczepanska-Sadowska E, et al. J Physiol Pharmacol. 2010 Oct;61(5):509-21. J Physiol Pharmacol. 2010. PMID: 21081794 Review. - Cognitive decline, dietary factors and gut-brain interactions.
Caracciolo B, Xu W, Collins S, Fratiglioni L. Caracciolo B, et al. Mech Ageing Dev. 2014 Mar-Apr;136-137:59-69. doi: 10.1016/j.mad.2013.11.011. Epub 2013 Dec 12. Mech Ageing Dev. 2014. PMID: 24333791 Review.
Cited by
- Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function.
Zhang L, Ebenezer PJ, Dasuri K, Fernandez-Kim SO, Francis J, Mariappan N, Gao Z, Ye J, Bruce-Keller AJ, Keller JN. Zhang L, et al. Am J Physiol Endocrinol Metab. 2011 Oct;301(4):E599-607. doi: 10.1152/ajpendo.00059.2011. Epub 2011 May 17. Am J Physiol Endocrinol Metab. 2011. PMID: 21586698 Free PMC article. - CYP1B1 deiciency ameliorates learning and memory deficits caused by high fat diet in mice.
Yang Z, Li H, Tang Y, Liu X, Liao Q, Fan C, Wang S. Yang Z, et al. Am J Transl Res. 2019 Apr 15;11(4):2194-2206. eCollection 2019. Am J Transl Res. 2019. PMID: 31105828 Free PMC article. - Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology.
Dunn TN, Adams SH. Dunn TN, et al. Adv Nutr. 2014 Jul 14;5(4):386-93. doi: 10.3945/an.113.005439. Print 2014 Jul. Adv Nutr. 2014. PMID: 25022988 Free PMC article. Review. - High-fat diet transition reduces brain DHA levels associated with altered brain plasticity and behaviour.
Sharma S, Zhuang Y, Gomez-Pinilla F. Sharma S, et al. Sci Rep. 2012;2:431. doi: 10.1038/srep00431. Epub 2012 May 30. Sci Rep. 2012. PMID: 22666534 Free PMC article. - A sexually dimorphic hypothalamic response to chronic high-fat diet consumption.
Morselli E, Frank AP, Palmer BF, Rodriguez-Navas C, Criollo A, Clegg DJ. Morselli E, et al. Int J Obes (Lond). 2016 Feb;40(2):206-9. doi: 10.1038/ijo.2015.114. Epub 2015 Jun 15. Int J Obes (Lond). 2016. PMID: 26073655 Review.
References
- Allen FM. Studies concerning glycosuria and diabetes. Harvard Univ Press; 1913. p. 982.
- DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787–835. - PubMed
- Vaag A. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights. Dan Med Bull. 1999;46:1997–234. - PubMed
- Goldstein BJ. Insulin resistance: from benign to type 2 diabetes mellitus. Rev Cardiovasc Med. 2003;4:S3–S10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG025771-03/AG/NIA NIH HHS/United States
- AG025771/AG/NIA NIH HHS/United States
- P01 AG005119-210011/AG/NIA NIH HHS/United States
- P01 AG005119/AG/NIA NIH HHS/United States
- R01 AG029885-03/AG/NIA NIH HHS/United States
- P30 DK072476/DK/NIDDK NIH HHS/United States
- AG005119/AG/NIA NIH HHS/United States
- R01 AG025771/AG/NIA NIH HHS/United States
- R01 AG029885/AG/NIA NIH HHS/United States
- AG029885/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical